Insider trade

Yarrow Bioscience (YARW): Director bought ~$44K

Patrick G Lepore, Director at Yarrow Bioscience, bought ~$44K of Yarrow Bioscience shares.

~$44K
Approx. value · 15K sh @ $2.92
51K
Holds after · shares reported
Traded
Jan 15, 2025
Filed
Jan 16, 2025

What stands out in this filing

  • The purchase added 41.1% to the shares this insider held before it; the filing reports 51,472 shares afterwards.
  • 15,000 shares at an average of $2.92 each, as reported on the form.

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Yarrow Bioscience

For Yarrow Bioscience, OQRO holds 8 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its YARW page.

How this filing works

Explore the data

Common questions

Which Yarrow Bioscience (YARW) insider traded, and how much?

Patrick G Lepore, Director at Yarrow Bioscience, bought ~$44K of Yarrow Bioscience shares. 15K shares at $2.92, open market.

When did it happen, and when was it made public?

Traded: Jan 15, 2025. Filed: Jan 16, 2025. That is 1 day between the two dates.

What stands out in this filing?

The purchase added 41.1% to the shares this insider held before it; the filing reports 51,472 shares afterwards. 15,000 shares at an average of $2.92 each, as reported on the form.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Yarrow Bioscience recently?

For Yarrow Bioscience, OQRO holds 8 fund holdings reports (13F) dated in the last 90 days. They are listed on the YARW page.

Does this mean YARW stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Yarrow Bioscience

Everything OQRO holds on this company is on its YARW page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data